Schizophrenia Polygenic Risk During Typical Development Reflects Multiscale Cortical OrganizationMatthias Kirschner, Alain Dagher, Foivos Georgiadis et al.|Biological Psychiatry Global Open Science|2022Cited by 12
Schizophrenia polygenic risk during typical development reflects multiscale cortical organizationMatthias Kirschner, Alain Dagher, Casey Paquola et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4
Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational StudyUshma Purohit, Michael Fralick, Chana A. Sacks et al.|Journal of General Internal Medicine|2023Cited by 3
Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded TrialsEmily Hughes, Michael Fralick, Tamara Van Bakel et al.|The Journal of Law Medicine & Ethics|2024Cited by 2
Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional studyBenazir Hodzic-Santor, Michael Fralick, Chana A. Sacks et al.|PLoS ONE|2023Cited by 0